9th Oct 2020 10:37
(Alliance News) - IP Group PLC on Friday said portfolio company Oxford Nanopore Technologies Ltd's LamPORE test is now CE marked for detecting the virus that causes Covid-19.
The CE mark means that the test meets EU standards and can be sold in countries accepting the mark. LamPORE is CE marked for in vitro diagnostic use in detecting the SARS-CoV-2 virus using Oxford Nanopore's GridION device.
The LamPORE test is now its its initial roll out in the UK, Germany, Switzerland, and the UAE. Oxford Nanopore has already partnered with the UK's Department of Health & Social Care with an initial order of 450,000 tests and the potential to increase to millions of tests per month.
Oxford Nanopore is pursuing regulatory approvals in other countries, including emergency use authorisation in the US and with partner G42 in the UAE.
Alan Aubrey, chief executive of IP Group, said: "Oxford Nanopore has made exceptional technical progress this year while playing a critical role to help support the response to the pandemic. The team at Oxford Nanopore has done an incredible job of bringing this innovative testing platform to market in such a short space of time. Oxford Nanopore is a great example of the kind of world-changing innovation that IP Group backs and supports from the beginning and we are delighted to see the company go from strength to strength."
Shares in IP Group were up 0.1% at 79.10 pence in London on Friday morning.
By Anna Farley; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Ip Group